Second, many available studies are characterized by small sample sizes or lack appropriate control groups, making it difficult to draw definitive conclusions about therapeutic efficacy and optimal treatment protocols
Our Seattle-area members stay at the forefront of GLP-1-related cosmetic innovations, regularly sharing knowledge and refining techniques specific to this patient population
Evaluation for other etiologies (fibroids, polyps, thyroid dysfunction, perimenopause) is warranted
Medspas and telehealth weight loss programs, however, often operate without these controls
Glucagon-like Peptide-1 (GLP-1) Agonists in Clinical Practice This section will give in-depth information about the existing local and systemic options in the current treatment paradigm for all the potential indications, in which most pharmaceutical companies are actively evaluating their inhibitors